Paragon Care
(ASX:PGC) has reported its gross profit rose 26 per cent to $46.1 million, in the 30 June 2017 financial year, compared for FY16.
The medical equipment company’s EBITDA advanced 41 per cent to $17.1 million.
In more good news, its revenue also strengthened, rising 25 per cent to $117.2 million, compared to the prior corresponding period.
The company says its bolstered results come from strong organic growth and stronger earnings from its FY16 purchases of Western Biomedical, Designs for Vision and Meditron.
Meantime, its total dividend for FY17 rose 36 per cent to 3 cents per share.
Shares in Paragon Care
(ASX:PGC) are trading is trading 8.02 per cent higher to $0.88.
